IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
STERCULIA QUADRIFIDA R.BR ETHYL ACETATE FRACTION INCREASES CISPLATIN CYTOTOXICITY ON T47D BREAST CANCER CELLS

Author: ROLLANDO ROLLANDO, KESTRILIA REGA PRILIANTI
Abstract: Cisplatin is a chemotherapeutic agent used as cancer cure with side effects and resistance. Ethyl acetate fraction of faloak bark (EAFB) are proven to have cytotoxic effect to cancer cells. This research aims to review the combination effect of cisplatin and EAFB to the sensitivity increase on breast cancer cells, which will be confirmed through apoptosis induction and cell cycle modulation. The cytotoxic effect was tested using MTT assay on T47D cell by using IC50 parameter. The combination was tested by determining their combination index (CI) and cell viability. The combination effect in apoptosis induction and cell cycle modulation were observed using flow cytometry method. The cytotoxic test result of the combination shows CI value of below 1 at the concentration of EAFB as much as 6 µg/mL, and cisplatin as much as 2,5 µM. The combination of EAFB and cisplatin results in phase S cell accumulation (29,98%) on breast cancer cell T47D and was able to induct apoptosis. It is proven that ethyl acetate fraction of faloak bark can be developed as a co-chemotherapeutic agent with cisplatin to increase the effectivity of breast cancer treatment
Keyword: Cisplatin, EAFB, cytoxicity, cell cycle, apoptosis
DOI: https://doi.org/10.31838/ijpr/2018.10.03.072
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477